1. Cancer Surgery and COVID19

   • The COVID19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering

   Health Services Research and Global Oncology 13 April 2020 Pages: 1713 - 1716

2. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations

   • David L. Bartlett
   • James R. Howe
   • for the Society of Surgical Oncology

   Health Services Research and Global Oncology 08 April 2020 Pages: 1717 - 1720

3. Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline

   • Kandace P. McGuire
   • Eleftherios P. Mamounas

   Breast Oncology 03 April 2020 Pages: 1721 - 1723

4. Rural Cancer Care: The Role of Space and Place in Care Delivery

   • Andrew P. Loehrer
   • Carrie H. Colla
   • Sandra L. Wong

   Health Services Research and Global Oncology 19 March 2020 Pages: 1724 - 1725

5. The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection: Moving from Initial Adoption to Thoughtful Dissemination

   • Daniel A. Anaya
   • Ugwuji Maduekwe
   • Jin He

   Pancreatic Tumors 17 March 2020 Pages: 1726 - 1729

6. A Textbook Answer to the Debate About Medicare’s Prospective Payment System Exemption?

   • Brian C. Brajcich
   • Ryan P. Merkow

   Hepatobiliary Tumors 07 April 2020 Pages: 1730 - 1732

7. Fibrolamellar Carcinoma: Novel Insights into a Rare Subtype

   • Asish Patel
   • N. Joseph Espat
   • Ponnandai Somasundar

   Hepatobiliary Tumors 13 February 2020 Pages: 1733 - 1734

8. Centralization of Health Care to Facilitate Greater Use of Nephron-Sparing Surgery for Localized Renal Tumors: Identifying Appropriate Health Care Delivery

   • Jeffrey C. Morrison
   • Boris Gershman
   • Simon P. Kim

   Urologic Oncology 23 January 2020 Pages: 1735 - 1736

9. The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction

   • Chicago Consensus Working Group

   Peritoneal Surface Malignancy 13 April 2020 Pages: 1737 - 1740

10. The Chicago Consensus on Peritoneal Surface Malignancies: Methodology

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1741 - 1742

    

11. The Chicago Consensus on Peritoneal Surface Malignancies: Standards

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1743 - 1752

12. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1753 - 1760

    

13. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1761 - 1767

    

14. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1768 - 1773

    

15. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1774 - 1779

    

16. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1780 - 1787

    

17. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1788 - 1792

    

18. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1793 - 1797

    

19. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations

    • Chicago Consensus Working Group

    Peritoneal Surface Malignancy 13 April 2020 Pages: 1798 - 1804

20. Breast Cancer Presentation, Surgical Management and Mortality Across the Rural–Urban Continuum in the National Cancer Database

    • Samilia Obeng-Gyasi
    • Lava Timsina
    • David A. Haggstrom

    Health Services Research and Global Oncology 23 March 2020 Pages: 1805 - 1815

    

21. ASO Author Reflections: Tackling Breast Cancer Disparities in Rural America: An Old Challenge in a New Decade

    • Samilia Obeng-Gyasi
    • David Haggstrom

    ASO Author Reflections 28 March 2020 Pages: 1816 - 1817

22. Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study

    • Mathias Neron
    • Christophe Sajous
    • The French Sarcoma Group (GSF-GETO)

    Breast Oncology 27 January 2020 Pages: 1818 - 1827

    

23. ASO Author Reflections: How Far Should We Go in Local Management for a Localized Malignant Phyllodes Tumor of the Breast?

    • Mathias Neron
    • Nelly Firmin

    ASO Author Reflections 23 March 2020 Pages: 1828 - 1829

24. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy

    • Brianna L. Cohen
    • Amber L. Collier
    • Francis I. Macedo

    Breast Oncology 27 January 2020 Pages: 1830 - 1841

    

25. ASO Author Reflections: SLNB with RT May Be Sufficient in Occult Breast Cancer after NAC

    • Brianna L. Cohen
    • Francis I. Macedo

    ASO Author Reflections 10 March 2020 Pages: 1842 - 1843

26. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?

    • Christina A. Minami
    • Emily C. Zabor
    • Melissa L. Pilewskie

    Breast Oncology 02 January 2020 Pages: 1844 - 1851

    

27. ASO Author Reflections: Conceptualizing Risk in Women with Lobular Carcinoma In Situ

    • Christina Minami
    • Melissa L. Pilewskie

    ASO Author Reflections 03 April 2020 Pages: 1852 - 1853

28. Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery

    • Barbara L. Smith
    • Conor R. Lanahan
    • Michele A. Gadd

    Breast Oncology Open access 02 January 2020 Pages: 1854 - 1861

    

29. ASO Author Reflections: Image-Guided Margin Assessment for Breast Cancer

    • Barbara L. Smith
    • Bridget N. Kelly
    • Michele A. Gadd

    ASO Author Reflections 16 March 2020 Pages: 1862 - 1863

30. Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma

    • Giovanni Corso
    • Patrick Maisonneuve
    • Paolo Veronesi

    Breast Oncology 21 January 2020 Pages: 1864 - 1874

    

31. ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field

    • Giovanni Corso

    ASO Author Reflections 26 February 2020 Pages: 1875 - 1876

32. The Impact of Obesity on Patient-Reported Outcomes Following Autologous Breast Reconstruction

    • Jonas A. Nelson
    • Nikhil Sobti
    • Robert J. Allen Jr.

    Breast Oncology 06 December 2019 Pages: 1877 - 1888

    

33. Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery

    • Rittal Mehta
    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    Hepatobiliary Tumors 27 February 2020 Pages: 1889 - 1897

    

34. ASO Author Reflections: Chance of Textbook Outcome following Hepatopancreatic Surgery Varies Based on Cancer Center Designation

    • Rittal Mehta
    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    ASO Author Reflections 25 March 2020 Pages: 1898 - 1899

35. Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection

    • James D. McDonald
    • Shreya Gupta
    • Jonathan M. Hernandez

    Hepatobiliary Tumors 10 January 2020 Pages: 1900 - 1905

    

36. ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein

    • James D. McDonald
    • Jonathan M. Hernandez

    ASO Author Reflections 18 March 2020 Pages: 1906 - 1907

37. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis

    • Koshiro Morino
    • Satoru Seo
    • Shinji Uemoto

    Hepatobiliary Tumors 14 January 2020 Pages: 1908 - 1917

    

38. ASO Author Reflections: Defining Oligometastatic Recurrence in Biliary Tract Cancer

    • Koshiro Morino
    • Tomoaki Yoh
    • Satoru Seo

    ASO Author Reflections 13 March 2020 Pages: 1918 - 1918

39. A Translational Approach to Standardization of Machine Perfusion Adoption in Ex Vivo Liver Resection

    • Enrico Gringeri
    • Pasquale Auricchio
    • Umberto Cillo

    Hepatobiliary Tumors 03 January 2020 Pages: 1919 - 1919

40. Trends in Renal Tumor Surgery in the United States and Germany Between 2006 and 2014: Organ Preservation Rate Is Improving

    • Luka Flegar
    • Christer Groeben
    • Johannes Huber

    Urologic Oncology 10 December 2019 Pages: 1920 - 1928

    

41. Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate Cancer

    • David F. Friedlander
    • Marieke J. Krimphove
    • Quoc-Dien Trinh

    Urologic Oncology 17 December 2019 Pages: 1929 - 1936

    

42. Papillary Thyroid Cancers of the Thyroid Isthmus: The Pattern of Nodal Metastasis and the Significance of Extrathyroidal Extension

    • Jungirl Seok
    • June Young Choi
    • Woo-Jin Jeong

    Endocrine Tumors 22 January 2020 Pages: 1937 - 1944

    

43. ASO Author Reflections: Characteristics of Papillary Thyroid Cancer of Thyroid Isthmus and Clinical Implications of Its Extrathyroidal Extension

    • Jungirl Seok
    • Woo-Jin Jeong

    ASO Author Reflections 17 March 2020 Pages: 1945 - 1946

44. How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study

    • Luigi Pedone Anchora
    • Luigi Calrlo Turco
    • Giovanni Scambia

    Gynecologic Oncology 02 January 2020 Pages: 1947 - 1955

    

45. Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study

    • Konstantinos I. Votanopoulos
    • Steven Forsythe
    • Aleksander Skardal

    Melanoma 19 December 2019 Pages: 1956 - 1967

    

46. ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy

    • Konstantinos I. Votanopoulos
    • Aleksander Skardal

    ASO Author Reflections 17 March 2020 Pages: 1968 - 1969

47. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease

    • Abhineet Uppal
    • Stacey Stern
    • Mark B. Faries

    Melanoma 20 December 2019 Pages: 1970 - 1977

    

48. Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?

    • C. R. Farley
    • M. C. Perez
    • M. C. Lowe

    Melanoma 26 February 2020 Pages: 1978 - 1985

    

49. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study

    • Sanne Lof
    • Maarten Korrel
    • for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)

    Pancreatic Tumors Open access 17 December 2019 Pages: 1986 - 1996

    

50. Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States

    • Javier E. Ordonez
    • Caitlin A. Hester
    • Patricio M. Polanco

    Pancreatic Tumors 01 January 2020 Pages: 1997 - 2006